These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 29880011)

  • 1. IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis.
    Jo S; Wang SE; Lee YL; Kang S; Lee B; Han J; Sung IH; Park YS; Bae SC; Kim TH
    Arthritis Res Ther; 2018 Jun; 20(1):115. PubMed ID: 29880011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated osteogenic differentiation of human bone-derived cells in ankylosing spondylitis.
    Jo S; Kang S; Han J; Choi SH; Park YS; Sung IH; Kim TH
    J Bone Miner Metab; 2018 May; 36(3):307-313. PubMed ID: 28589411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3 phosphorylation inhibition for treating inflammation and new bone formation in ankylosing spondylitis.
    Jo S; Won EJ; Kim MJ; Lee YJ; Jin SH; Park PR; Song HC; Kim J; Choi YD; Kim JY; Shim SC; Choi SH; Park YS; Kim TH; Kim TJ
    Rheumatology (Oxford); 2021 Aug; 60(8):3923-3935. PubMed ID: 33237331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of osteoblasts by alkaline phosphatase in ankylosing spondylitis.
    Jo S; Han J; Lee YL; Yoon S; Lee J; Wang SE; Kim TH
    Int J Rheum Dis; 2019 Feb; 22(2):252-261. PubMed ID: 30415492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [H3K27me3 Expression Level and Its Epigenetic Regulation Mechanisms in Th17 Cell Differentiation in Patients With Ankylosing Spondylitis].
    Cheng M; Jia L; Xue Z; Yang T; Zhou X; Zhao G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 May; 55(3):744-748. PubMed ID: 38948276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-214 stimulated by IL-17A regulates bone loss in patients with ankylosing spondylitis.
    Liu Z; Huang F; Luo G; Wang Y; Du R; Sun W; Li J; Yuan X; Cao D; Li Y; Liu C; Liang S; Jin X; Ling S; Wang D; Li Y
    Rheumatology (Oxford); 2020 May; 59(5):1159-1169. PubMed ID: 31846044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway.
    Ying L; Yao Y; Lv H; Lu G; Zhang Q; Yang Y; Zhou J
    Am J Physiol Cell Physiol; 2022 May; 322(5):C814-C824. PubMed ID: 35319902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel role for bone-derived cells in ankylosing spondylitis: Focus on IL-23.
    Jo S; Koo BS; Lee B; Kwon E; Lee YL; Chung H; Sung IH; Park YS; Kim TH
    Biochem Biophys Res Commun; 2017 Sep; 491(3):787-793. PubMed ID: 28728847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-17A expressed on neutrophil extracellular traps promotes mesenchymal stem cell differentiation toward bone-forming cells in ankylosing spondylitis.
    Papagoras C; Chrysanthopoulou A; Mitsios A; Ntinopoulou M; Tsironidou V; Batsali AK; Papadaki HA; Skendros P; Ritis K
    Eur J Immunol; 2021 Apr; 51(4):930-942. PubMed ID: 33340091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High level of interleukin-32 gamma in the joint of ankylosing spondylitis is associated with osteoblast differentiation.
    Lee EJ; Lee EJ; Chung YH; Song DH; Hong S; Lee CK; Yoo B; Kim TH; Park YS; Kim SH; Chang EJ; Kim YG
    Arthritis Res Ther; 2015 Dec; 17():350. PubMed ID: 26634249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ohwia caudata extract relieves the IL-17A-induced inflammatory response of synoviocytes through modulation of SOCS3 and JAK2/STAT3 activation.
    Lu CY; Kuo CH; Kuo WW; Hsieh DJ; Wang TF; Shih CY; Lin PY; Lin SZ; Ho TJ; Huang CY
    Environ Toxicol; 2023 Aug; 38(8):1914-1924. PubMed ID: 37163279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Punicalagin Exerts Protective Effects against Ankylosing Spondylitis by Regulating NF-
    Feng X; Yang Q; Wang C; Tong W; Xu W
    Biomed Res Int; 2020; 2020():4918239. PubMed ID: 33029510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential function of miR-135b-mediated JAK2/STAT3 signaling pathway during osteoblast differentiation.
    Zhang XT; Sun M; Zhang L; Dai YK; Wang F
    Kaohsiung J Med Sci; 2020 Sep; 36(9):673-681. PubMed ID: 32319222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dihydrotestosterone on osteoblast activity in curdlan-administered SKG mice and osteoprogenitor cells in patients with ankylosing spondylitis.
    Jo S; Lee EJ; Nam B; Kang J; Lee S; Youn J; Park YS; Kim YG; Kim TH
    Arthritis Res Ther; 2020 May; 22(1):121. PubMed ID: 32448352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The advent of IL-17A blockade in ankylosing spondylitis: secukinumab, ixekizumab and beyond.
    Dubash S; Bridgewood C; McGonagle D; Marzo-Ortega H
    Expert Rev Clin Immunol; 2019 Feb; 15(2):123-134. PubMed ID: 30576610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DKK-1 Is Underexpressed in Mesenchymal Stem Cells from Patients with Ankylosing Spondylitis and Further Downregulated by IL-17.
    Daoussis D; Kanellou A; Panagiotopoulos E; Papachristou D
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental abdominal aortic aneurysm growth is inhibited by blocking the JAK2/STAT3 pathway.
    Xiao J; Wei Z; Chen X; Chen W; Zhang H; Yang C; Shang Y; Liu J
    Int J Cardiol; 2020 Aug; 312():100-106. PubMed ID: 32334849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of JAK2/STAT3 signaling suppresses bone marrow stromal cells proliferation and osteogenic differentiation, and impairs bone defect healing.
    Yu X; Li Z; Wan Q; Cheng X; Zhang J; Pathak JL; Li Z
    Biol Chem; 2018 Oct; 399(11):1313-1323. PubMed ID: 30044759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased sensitivity of rheumatoid synoviocytes to Schnurri-3 expression in TNF-α and IL-17A induced osteoblastic differentiation.
    Lavocat F; Osta B; Miossec P
    Bone; 2016 Jun; 87():89-96. PubMed ID: 27072520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells.
    Shah M; Maroof A; Gikas P; Mittal G; Keen R; Baeten D; Shaw S; Roberts SJ
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32723833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.